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Abstract
The pathology of many of the world’s most important infectious diseases is caused by the immune response. Additionally
age-related disease is often attributed to inflammatory responses. Consequently a reduction in infections and hence
inflammation early in life has been hypothesized to explain the rise in lifespan in industrialized societies. Here we
demonstrate experimentally for the first time that eliciting an immune response early in life accelerates ageing. We use the
beetle Tenebrio molitor as an inflammation model. We provide a proof of principle for the effects of early infection on
morbidity late in life and demonstrate a long-lasting cost of immunopathology. Along with presenting a proof-of-principle
study, we discuss a mechanism for the apparently counter-adaptive persistence of immunopathology in natural
populations. If immunopathology from early immune response only becomes costly later in life, natural selection on
reducing self-harm would be relaxed, which could explain the presence of immune self-harm in nature.
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Introduction
Inflammation has long-lasting health implications. Tissues
express the inflammatory response following trauma or infection,
providing the innate immune system’s first response to insult. In
the short term, inflammation constitutes a vital response to
immune injury as it is the key component of tissue repair and
reinstates physiological homeostasis [1]. However the initial acute
inflammatory response can develop into a chronic condition if
tissue health is not restored or irritation to the immune system is
maintained [2]. Exposure to inflammation has therefore been
linked to many diseases (reviewed in [3]), in which cases the
inflammatory process can cause more harm than the initial
immune insult [4]. In fact, the severity of many of the world’s most
important infectious diseases can largely be attributed to the
immunopathology of inflammation [5]. In addition, diseases
caused by inflammation are often associated with ageing, when
disease symptoms are not expressed until many years after the
initial inflammatory response [6]. These include cardiovascular
disease [7], cancer [8] and metabolic diseases [3].
Recently Caleb Finch and Eileen Crimmins [9,10] proposed
that a reduction in lifetime exposure to infectious disease and
subsequent reduced inflammation causes a decline in age-related
adult disease, i.e. a direct link between immunopathology
encountered in early life and a decrease in adulthood morbidity
and mortality. Most studies supporting this hypothesis have been
of epidemiological, correlational nature, and lack hypothesis-
driven experimental evidence. Experimental animal studies
provide very powerful means by which to investigate the
mechanisms controlling how environments in early life impact
on phenotype expression in human adulthood [11,12]. As insect
immunity also causes inflammation and immunopathology
[13,14], we have conducted a proof-of-principle study using the
mealworm beetle Tenebrio molitor. The similarities between the
underlying mechanisms of the insect and human innate immune
systems [15] have encouraged and confirmed the importance of,
the use of insect model systems in immunology. In T. molitor it has
been shown that an immune response leads to the damage of vital
organs, Malpighian tubules, which function equivalent to the
kidneys of vertebrates [16].
Moreover, during the pupal phase of development in T. molitor a
substantial proportion of the body is reconstructed: almost all
larval tissues get completely dissolved and remodelled. Most of the
gut is reconstructed during metamorphosis and shows different
larval versus adult morphologies, but the Malpighian tubules are
an exception and remain as intact structures [17,18,19,20]. This
allows us to exclude damage to other tissues as an underlying cause
of ageing phenotypes if the timing of the treatment shortly before
or after pupation does not affect aging rate. Taken together, we
have a model system where inflammatory damage to an organ
system has been demonstrated [16] and because the study was
designed to specifically test the impact of inflammation experi-
enced either before or after complete metamorphosis, we can
investigate damage to Malpighian tubules as a candidate
mechanism.
Here, we investigate whether experimental activation of
immune response early in life affects ageing measured as
maximum lifespan. To measure the costs of immune activation
and inflammation without any concurrent cost of infection, we
activated the immune system at an early life stage with two non-
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nylon filament, both of which elicit an immune response [21,22].
Animals were challenged either at the larval stage, 70 days post-
hatching, or the adult stage, 8 days post-adult-eclosion. The
procedural controls received an injection with sterile insect ringer,
and full controls were not subjected to any immune injury. We
analysed maximum lifespan to specifically measure aging [23,24],
and also medium lifespan.
Results
Maximum lifespan
Early-life immune response accelerated ageing, as shown by a
reduction in maximum lifespan. The maximum lifespan value for
each experimental group was below that of the Control group
(Table 1). Each group had a different maximum lifespan as the
90
th percentile of survival time was calculated for each group
separately.
In order to test for differences in maximum lifespan between
experimental groups, the 90
th percentile of overall survival time
when all groups were combined were calculated. This value was
219 days. The percentage of each group reaching this maximum
lifespan was compared to the percentage of the control (Fig. 1). An
Exact Unconditional z-pooled test, which is argued to be more
powerful for comparing two populations than the standard
unconditional tests (Berger, 1996), was used to compare
percentages. All experimental groups that had been immune
challenged early in life exhibited significantly shorter maximum
lifespan than the control group (percentage of individuals reaching
219 days was significantly lower, P,0.03 in all cases, Table 2).
Pooling all immune challenged groups, i.e. larval or adult
challenge with either nylon or bacteria, and comparing them to
the pooled procedural control, showed a significant effect of
immune challenge on shortening maximum lifespan (Exact
Unconditional Independence Test: Test Statistic=22.60,
P=0.01). The effect of accelerated ageing was seen in all
immune-challenged groups, independent of whether the immune
response was elicited before or after pupation. Differences between
groups challenged either before or after pupation were non-
significant (P.0.5 in all comparisons).
Median lifespan
The analysis of median lifespan using the accelerated failure time
model showed the same overall directional pattern as maximum
lifespan – full controls had the longest lifespan, followed by both
procedural control groups, and the four immune challenged groups
suffered the shortest lifespan (Fig. 2, table 3). The c-parameter,
which is a treatment effect averaged among all survival time
quantiles (i.e. the shift of the survival curve), was consistently lower
when experimental treatments were compared against the control
(Fig. 2). As a reference point, a treatment effect was calculated when
control is compared against itself, and this value was the highest on
the y-axis, confirming that early-life immune response initiates a
reduction in median lifespan. Confidence intervals for these
treatment effects did not overlap with the intervals of the control
‘reference point’ treatment effect (Table 3).
In the overall pooled comparison, procedural controls did not
differ from immune challenged groups in median lifespan (Exact
Unconditional Test: test statistic=20.02, P=0.49), unlike in
maximum lifespan. However, compared to full controls there was
significantly reduced median lifespan in individuals treated with
either the control injection or immune antigens when all immune
challenged and procedural control groups were pooled together
(Chi-Squared Test: x
2=13.68, P=0.0002).
Physiological condition in mid-adult life
In a study that closely mirrored the experimental procedures of
the main study presented here, we asked if the results could be
driven by a resource trade-off. Our data do not show an indication
of such a trade-off as levels of the enzyme phenoloxidase in the
mid-adult stage were not affected by early-life immune challenge
(ANOVA: F=0.5727; df=4; P=0.6828; Fig. 3).
Discussion
The same ageing phenotype – a reduction in median and
maximum lifespan - is observed when an immune insult is
generated by a variety of different antigens, either before or after
metamorphosis. This proof-of-principle that early-life inflamma-
tion causes reduced adult survival is important for two types of
study that have covered this topic; firstly, clinical experiments
indicating links between inflammation and adult disease
[3,7,25,26,27,28,29] and secondly, studies showing that birth
cohorts experiencing high levels of early-life mortality also
experience reduced lifespan [6,30,31].
We also investigated the notion that the aging phenotypes could
be caused by a resource trade-off investigating the role of
phenoloxidase, a crucial component of the innate immune system.
Briefly, this is an enzyme involved in two major processes; i) the
catalisation of the oxidation of tyrosine to 3,4-dihydroxyphenyla-
nanine; and ii) melanisation [32]. It also has been demonstrated to
be condition dependent ([33]). Our results indicate that immune
challenges did not cause phenoloxidase to be upregulated in the
long term. This is in concordance with previous experimentation
showing that Tenebrio molitor immune response ceases 28 days
following infection [34].
The phenoloxidase response is associated with tissue damage in
Tenebrio molitor [16]. Since phenoloxidase levels in our study did not
appear to be upregulated in the long-term, we can confidently
hypothesise that the observed lifespan reduction was not caused by
repeated tissue damage from persistent phenoloxidase. Instead, we
suggest that immunopathological damage suffered at the time of
inflammation and expressed later in life is the parsimonious
explanation for our findings. In support of this the experimental
procedure elicited an immune response without a living pathogen.
Moreover, the effects of immune response were delayed, with the
first mortality detected 64 days following infection (Figure S1).
Further evidence to support our hypothesis that immunopa-
thology is an important mechanism behind the long-term cost of
early-life inflammation comes from our investigation into the
Table 1. 90
th percentile survival times for each experimental
group.
Treatment Group
Maximum Lifespan: 90
th
Percentile Survival Time (Days)
Control 224
Procedural Control 1 219
Procedural Control 2 218
Nylon Larval Stage 205
Nylon Adult Stage 198
Bacteria Larval Stage 195
Bacteria Adult Stage 193
(Groups are listed in descending order of maximum lifespan).
doi:10.1371/journal.pone.0019972.t001
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complete metamorphosis did not affect the results. This may
suggest that inflammation-associated tissue damage contributing to
lifespan reduction is carried through complete metamorphosis. In
support of this, Malpighian tubules have been shown to be
particularly sensitive to immunopathology in T. molitor, suffering
Figure 1. Early-life immune challenge accelerates ageing. ‘Ageing acceleration’ on the y-axis represents the reduction in maximum lifespan
caused by the treatments (the percentage of survivors to the 90
th percentile in the control group/the percentage of survivors to the 90
th percentile in
the treatment group). The dashed line represents the point at which the difference in aging acceleration between Control and experimental groups
becomes statistically significant. Control n=133; Procedural Control 1 n=69; Procedural Control 2 n=62; Nylon Larval Stage n=97; Bacteria Adult
Stage n=29; Bacteria Larval Stage n=58; Nylon Adult Stage n=32. Experimental groups were as follows: Control=no experimental manipulation in
larval or adult stage; Procedural Control 2=injection with sterile insect ringer in larval stage only; Procedural Control 1=injection with sterile insect
ringer in both larval and adult stage; Larval stage nylon=insertion of nylon filament in larval stage, and injection of sterile insect ringer in adult stage;
Larval stage bacteria=injection of dead bacteria in larval stage, and injection of sterile insect ringer in adult stage; Adult stage bacteria=injection of
sterile insect ringer at larval stage and injection of dead bacteria in adult stage; Adult stage nylon=injection of sterile insect ringer in larval stage and
insertion of nylon filament in adult stage.
doi:10.1371/journal.pone.0019972.g001
Table 2. Maximum lifespan analysis using Exact Unconditional Independence (z-pooled) test.
Comparison Treatment Effect Test Statistic Exact Unconditional (z-pooled) P-value
Control vs. PC1 1.68 21.54 0.128
Control vs. PC2 1.95 21.78 0.077
Control vs. NLS 3.55 23.28 0.002
Control vs. BLS 6.37 23.18 0.003
Control vs. BAS 6.37 22.32 0.028
Control vs. NAS 7.02 22.47 0.017
Treatment effects and p-values for comparing each group against Control, in terms of the proportion of individuals reaching 90
th percentile of overall survival time (219
days). Treatment groups: PC1=Procedural Control 1; PC2=Procedural Control 2; NLS=Nylon Larval Stage; BLS=Bacteria Larval Stage; BAS=Bacteria Adult Stage;
NAS=Bacteria Adult Stage.
doi:10.1371/journal.pone.0019972.t002
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insect ‘kidneys’, and are among the organs of the insect body that
are not completely reconstructed during metamorphosis from
larva to adult [19,20].
We propose that an initial immune response and upregulation
of phenoloxidase could have inflicted harm on Malpighian tubules
that persisted into adult life and caused reduced lifespan. If this
were to indicate a general evolutionary mechanism, it is possible
that the link between childhood inflammation and reduced
lifespan observed by Finch and Crimmins [9] could be driven
by immunopathological damage incurred during inflammation,
the long-lasting effects of which are carried through to adulthood.
Whilst our data are consistent with the notion that early
inflammation leads to increased aging mediated by innate
responses, the question remains if this observation relates also to
vertebrates. Vertebrates have a more complex immune system, the
acquired immune system, yet inflammation and immunopathology
in vertebrates has also been shown to be partly mediated by NF-kB
mediated innate responses. The latter are highly conserved and
form an important part of insect immunity ([35,36,37].
In an evolutionary context, we would like to argue that
immunopathology could play a role in organisms in the wild. Costs
of immune responses become exacerbated under environmental
stress [38] and hence any effect on the aging phenotype will be
shifted forward in an individual’s lifespan and become subject to
natural selection. Moreover a recent study demonstrated for the
first time that insect populations in the wild senesce, exhibiting
age-dependent survivorship [39]. Alternatively, immunopathology
could provide an explanation for the ‘paradox of aging science’
[40]: aging (i.e. reduction in maximum lifespan) is present in most
species yet it directly opposes natural selection for maintenance
systems. An immune response constitutes a trade-off between the
Figure 2. Early-life immune challenge reduces median longevity. Each c-parameter represents the percent difference in lifespan when each
experimental group is compared with the control group, for any survival quantile. Error bars represent 95% confidence intervals.
doi:10.1371/journal.pone.0019972.g002
Table 3. c-Parameter estimates and confidence intervals from
AFT model. Data are displayed in descending order of c-
Parameter.
Group c-Parameter Lower CI Upper CI
Control 1.000 0.96 1.044
Procedural Control 1 0.948 0.890 1.008
Procedural Control 2 0.933 0.872 0.998
Nylon Larval Stage 0.893 0.836 0.953
Bacteria Adult Stage 0.891 0.822 0.965
Bacteria Larval Stage 0.882 0.828 0.939
Nylon Adult Stage 0.836 0.767 0.910
doi:10.1371/journal.pone.0019972.t003
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harm only present at a later stage in life, and cause acceleration in
aging but not a reduction in median lifespan, then natural
selection on reducing self-harm will be weak.
Materials and Methods
Animal rearing
Pupae were collected from stock cultures maintained at 2562uC
with ad libitum supply of food and water. Following emergence and
development to sexual maturity, adults were set up in mating pairs.
The eggs from these mating events were to become experimental
animals. During development, larvae were maintained at similar
densities and with ad libitum access to food and water.
Treatment groups
At day 70 post-hatch, larvae were taken from stock culture and
placed in individual plastic cups. They were randomly assigned to
one of four treatments; dead bacteria, nylon, procedural control or
full control. Within these treatment groups, individuals were
randomly assigned to one of two treatment stages; larval stage or
adult stage. Larval stage was day 70 post-hatch; adult stage was
day 8 post-adult eclosion, at which stage individuals had reached
sexual maturity. Full control individuals remained in their cups
throughout the treatment period. After treatment, larvae were
placed back into their cups and maintained at 2562uC with ad
libitum supply of food and water. Age at death was recorded.
The treatment groups were as follows:
Dead bacteria in larval stage; sterile ringer in adult stage
Nylon in larval stage; sterile ringer in adult stage
Sterile ringer in larval stage, sterile ringer in adult stage
Sterile ringer in larval stage; dead bacteria in adult stage
Sterile ringer in larval stage; nylon in adult stage
Sterile ringer in larval stage; no treatment in adult stage
No treatment in either stage (full control)
Bacterial culturing
Serratia marcescens was taken from glycerol stocks and grown
up overnight in Luria broth (tryptone 10 g, yeast extract 5 g, NaCl
Figure 3. Mean haemolymph phenoloxidase activity of different experimental groups, measured as mean Vmax. Error parts convey
standard errors. Bacteria, n=23; Control, n=76; Nylon, n=51; Stab, n=33; Water, n=23.
doi:10.1371/journal.pone.0019972.g003
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and grown overnight. A single colony from this plate was grown
overnight in another Luria broth culture. This culture was then
killed by heat shock in a water bath and autoclaved.
Dead bacteria experimental treatment
Before treatment, larvae and adults were chilled on ice for
5 minutes. 5 ml of dead Serratia marcescens culture was pipetted onto
parafilm, then taken up by a glass capillary. An incision was made
in between the 3
rd and 4
th ventral abdominal sternites of
experimental animals using a sterile 0.5 mm diameter needle.
The bacterial culture was then expelled into the haemocoel. The
dosage was approximately 3000 cells/5 ml.
Nylon experimental treatment
Animals were chilled prior to infection, and an incision on the
ventral side of the body was made, as described for the dead
bacteria treatment. A 2 mm60.16 mm piece of sterile nylon
(Tenax) was inserted into the haemocoel through the incision.
Sterile ringer treatment (procedural control)
Insect ringer (NaCl 128 mM, CaCl2 18 mM, KCL 1.3 mM,
NaHCO3 2.3 mM) was pushed through a Sartorius Ministart RC
25 mm60.2 mm filter. 5 ml ringer was injected using the method
described for the dead bacteria treatment.
Phenoloxidase activity 4 weeks after challenge
Tenebrio molitor larvae at the final instar stage were
obtained from Livefood (www.livefoods.co.uk) and maintained
in stock cultures (.100 larvae per culture) with ad libitum
access to food and water. Individuals from each stock culture
were randomly assigned to each experimental group (Table S1).
Following experimental treatment at the larval stage, animals
were placed into individual plastic cups with ad libitum access
to water in the form of potato chunks. Beetles remained in these
plastic cups throughout the experiment. On the day of adult
eclosion, food in the form of rat chow was added to the cup and
maintained at ad libitum levels. Adult-stage stab treatments
were administered 8 days following adult eclosion. These stabs
were intended to mimic the fact that most groups in the
experiments of the main study underwent an experimental
procedure in the adult stage, and therefore the results from this
experiment could potentially infer information about the
patterns in phenoloxidase levels that may have occurred in
the main study.
Haemolymph removal
On day 30 post-adult eclosion, beetles were chilled and then
stabbed in the soft cervical membrane between the head and
thorax. Haemolymph was removed directly from the stab wound
using a pipette (Gilson Pipetman P20) and immediately frozen at
290uC. A minimum of 2 ml of haemolymph was collected from
each beetle: if the beetle failed to yield this amount, it was
discarded from the experiment.
Measurement of haemolymph phenoloxidase activity
The phenoloxidase assay from [34] was used. Reagents and
reactions were kept chilled on ice at all times prior to
spectrophotometric measurement. Haemolymph was defrosted
on ice and diluted to a ratio of 1:20 neat haemolymph:phosphate-
buffered saline (NaCl 150 mM; Na2HPO4 10 mM; pH 6.5). This
mixture was then centrifuged at 12,200 rcf using an Eppendorf
5417R centrifuge. 8 ml of the supernatent was added to a well on a
96-well spectophotometer plate along with 56 ml sterile distilled
water and 8 ml phosphate-buffered saline. Each well therefore
contained a separate sample. L-DOPA (4 mg ml
21) was dissolved
in sterile distilled water by mixing vigorously for at least
10 minutes. This concentration of L-DOPA has been previously
shown to be a suitable concentration to use for the measurement of
phenoloxidase activity in Tenebrio molitor haemolymph [34] The
solution was then pushed through a Sartorius Ministart RC
25 mm60.2 mm filter to remove any remaining particles of L-
DOPA. 8 ml L-DOPA was added to each well on the plate, and
the plate was immediately placed in a spectophotometer
(Molecular Devices VERSAmax) and the measurement started.
The specific reaction in the spectophotoeter was as follows: 60-
minute kinetic reaction, with readings every 15 seconds; plate
mixed by shaking before each measurement; incubated at 30uC.
The rate at which phenoloxidase in each well converted to
dopachrome was measured, and this enzyme activity was given in
the form of Vmax, which directly correlated with the amount of
phenoloxidase in the original haemolymph sample ([41]). For each
sample, the reduced data was viewed in plot form on the
spectophotometer, and the Vmax over the period of time where
the reaction proceeded in a straight line was taken. This was done
to remove distortion of the results caused by periods of lag or
levelling-off.
Statistical analyses of maximum and median lifespan
The statistical package R was used for analysis. We examined
the difference between each treatment group and control in terms
of median and maximum lifespan. To examine median lifespan,
we ran accelerated failure time models, with each model
representing a treatment group compared to full control. This
analysis was based on a paper by William Swindell [23]. The
distribution to use in the AFT models was decided by producing
parametric survival models for each comparison, with the
following distributions: Weibull, Exponential, Lognormal and
Gaussian. We then used analysis of variance to test which
distribution minimised Akaike’s Information Criterion, and was
therefore the appropriate distribution to use [42]. For each
comparison of experimental and control group, the Weibull
distribution was appropriate (see table S2; plots available on
request). Quantile-quantile plots of the data from each AFT
model indicated that the effects treatment were not always
consistent over time, because the data did not form straight lines.
Therefore, we can say that the c-values generated by the AFT
model represent effects of treatment on survival, averaged over
survival time. Each model produced a c-parameter, which
represented the difference in median lifespan between the two
groups, and 95% confidence intervals for this value. A treatment
effect was then calculated. A value of 1 represents a c-parameter
when the full control group is compared against itself. Data from
accelerated failure time models are presented in table 3. To
examine maximum lifespan, we calculated the 90
th percentile
survival time when all treatment groups were combined. We then
worked out the percentage of individuals in each treatment group
surviving to this time. Exact unconditional tests, using a
contingency table approach with the online calculator at www.
stat.ncsu.edu/exact, were used to compare percentage survival
for control group with each treatment group in turn. This
produced a score-test z-pooled p-value for each of the seven
comparisons. To obtain the treatment effect, the percentage
survival of the full control group was divided by that of the
treatment group in each comparison. This maximum lifespan
method was based on that used by references 23 and 24 and the
data are displayed in table S3.
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Figure S1 Survival curves for each treatment group.
Dotted lines represent treatment groups that differed significantly
from full controls (p,0.05), when compared using a parametric
survival model with Weibull distributions. Treatment groups:
black solid=Control; brown solid=Procedural Control 1; grey
solid=Procedural Control 2; red dashed=Bacteria Larval Stage;
blue dashed=Bacteria Adult Stage; green dashed=Nylon Larval
Stage; yellow dashed=Nylon Adult Stage.
(PPT)
Table S1 Experimental groups. See Materials and Methods
Chapter for detail on experimental procedures and cohort design.
‘Larval stage’ refers to final instar before pupation; ‘adult stage’
refers to 8 days following adult eclosion. Stab and Water
experimental groups are procedural controls for the two
experimental groups, which are Bacteria and Nylon.
(DOC)
Table S2 Distributions of survival models. Analysis of
variance results when each experimental treatment was compared
with control, using different distributions. -2*LL value is the
Akaike’s Information Criterion.
(DOC)
Table S3 Delayed effects of immune response: earliest
point of overall survival time at which groups begin to
differ in survival. P-values from Chi-squared analysis using
7X2 contingency table are shown. By the 9
th quantile, 65 days,
some experimental groups (nylon-challenged) have begun to differ
significantly from other groups. Groups other than nylon, i.e.
bacteria-challenged and procedural controls, did not differ
significantly at day 69 (10
th quantile of overall survival time)
(P.0.23), but these groups did suffer significantly reduced survival
by day 120 (20
th quantile) (P,0.05).
(DOC)
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